S
Shattuck Labs D
D
STTK
1.12500
USD
-0.04
(-3.02%)
مغلق
حجم التداول
2,908
الربح لكل سهم
-1
العائد الربحي
-
P/E
-1
حجم السوق
53,707,172
المقالات
العنوان: Shattuck Labs
القطاع: Healthcare
الصناعة: Biotechnology
Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhibit the CD47/SIRPa checkpoint interaction to restore an anti-tumor immune response and to activate the CD40 costimulatory receptor to bolster an immune response. Its product candidate, SL-279252, which is being developed in collaboration with Takeda Pharmaceuticals, or Takeda, has been rationally designed to simultaneously inhibit the PD-1/PD-L1 interaction and activate the OX40 receptor.